The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial safety run-in results of the phase III POLARGO trial: Polatuzumab vedotin plus rituximab, gemcitabine, and oxaliplatin in patients (pts) with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).
 
Matthew J. Matasar
Stock and Other Ownership Interests - Merck
Honoraria - Bayer; Epizyme; Genentech; GlaxoSmithKline; Immunovaccine; Janssen; Pharmacyclics; Roche; Seagen; Takeda
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Genentech; Juno Therapeutics; Merck; Roche; Rocket Medical; Seagen; Takeda; Teva
Research Funding - Bayer; Genentech; GlaxoSmithKline; IGM Biosciences; IGM Biosciences; Immunovaccine; Janssen; Pharmacyclics; Roche; Rocket Medical; Seagen
Travel, Accommodations, Expenses - Bayer; Genentech; Roche; Seagen
 
Corinne Haioun
Honoraria - Amgen; Celgene; Gilead Sciences; Janssen-Cilag; Miltenyi Biotec; Roche; Takeda
 
Juan-Manuel Sancho
Honoraria - Bristol-Myers Squibb/Celgene; Janssen; Kite/Gilead; Roche; Takeda
Consulting or Advisory Role - BeiGene; Bristol-Myers Squibb/Celgene; Incyte; Janssen; Kite/Gilead; Lilly; Novartis; Roche
Travel, Accommodations, Expenses - Roche
 
Andreas Viardot
Honoraria - Amgen; Bristol-Myers Squibb; Kite/Gilead; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Kite/Gilead; Roche
 
Antonia Rodriguez Izquierdo
Research Funding - Roche (Inst)
 
Eva Maria Donato Martin
Consulting or Advisory Role - Abbvie; Incyte
Travel, Accommodations, Expenses - Janssen
 
Alejandro Martin Garcia-Sancho
Honoraria - Celgene; Eusa Pharma; Gilead Sciences; Janssen-Cilag; Novartis; Roche; SERVIER; Takeda
Consulting or Advisory Role - ADC Therapeutics; BMS; EUSA Pharma; Gilead Sciences; Incyte; iQONE; Kyowa Hakko Kirin; Lilly; MorphoSys; Novartis; Roche; SERVIER
Research Funding - Janssen (Inst); Teva (Inst)
Expert Testimony - Gilead Sciences
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Janssen Oncology; Kern Pharma; Roche; SERVIER
 
Jose David Sandoval-Sus
Consulting or Advisory Role - Incyte; Massive Bio; Morphosys; Seagen; TG therapeutics; TG Therapeutics
Speakers' Bureau - Celgene
 
Herve Tilly
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Incyte; Roche
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche
 
Elizabeth Vandenberghe
Consulting or Advisory Role - Kyowa Kirin
 
Jamie Hirata
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Priya Choudhry
Employment - Genentech
Stock and Other Ownership Interests - Amarin Corporation; Apellis Pharmaceuticals; NGM Biopharmaceuticals
 
Yi Meng Chang
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Lisa Musick
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche
 
Andrew McMillan
Honoraria - Amgen; Roche; Takeda
Consulting or Advisory Role - Roche; Takeda
Speakers' Bureau - Roche; Takeda
Travel, Accommodations, Expenses - Takeda